GMO (Jeremy Grantham) — ABT Trade History
Quarter-by-quarter changes in the ABBOTT LABORATORIES position · CUSIP 002824100
Currently held · >10 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Reduce | 8,794,077 | -116,868 | -1.3% | $798.0M | 1.80% |
| 2026 Q1 | 2026-05-14 | Add | 8,910,945 | 428,392 | +5.1% | $914.9M | 2.34% |
| 2025 Q4 | 2026-02-17 | Add | 8,482,553 | 306,069 | +3.7% | $1.06B | 2.72% |
| 2025 Q3 | 2025-11-13 | Add | 8,176,484 | 361,946 | +4.6% | $1.10B | 3.09% |
| 2025 Q2 | 2025-08-13 | Reduce | 7,814,538 | -293,045 | -3.6% | $1.06B | 3.20% |
| 2025 Q1 | 2025-05-14 | Add | 8,107,583 | 210,644 | +2.7% | $1.08B | 3.39% |
| 2024 Q4 | 2025-02-13 | Add | 7,896,939 | 787,251 | +11.1% | $893.2M | 2.91% |
| 2024 Q3 | 2024-11-13 | Add | 7,109,688 | 1,317,528 | +22.7% | $810.6M | 2.54% |
| 2024 Q2 | 2024-08-13 | Add | 5,792,160 | 384,152 | +7.1% | $601.9M | 2.03% |
| 2024 Q1 | 2024-05-14 | Add | 5,408,008 | 1,032,651 | +23.6% | $614.7M | 2.23% |
| 2023 Q4 | 2024-02-13 | Add | 4,375,357 | 710,501 | +19.4% | $481.6M | 2.13% |
| 2023 Q3 | 2023-11-13 | Add | 3,664,856 | 801,191 | +28.0% | $354.9M | 1.68% |
| 2023 Q2 | 2023-08-14 | Add | 2,863,665 | 1,215,172 | +73.7% | $312.2M | 1.45% |
| 2023 Q1 | 2023-05-12 | Add | 1,648,493 | 13,059 | +0.8% | $166.9M | 0.85% |
| 2022 Q4 | 2023-02-13 | Reduce | 1,635,434 | -15,800 | -1.0% | $179.6M | 0.96% |
| 2022 Q3 | 2022-11-10 | Add | 1,651,234 | 43,860 | +2.7% | $159.8M | 0.92% |
| 2022 Q2 | 2022-08-12 | Reduce | 1,607,374 | -40,129 | -2.4% | $174.6M | 0.95% |
| 2022 Q1 | 2022-05-13 | Reduce | 1,647,503 | -41,277 | -2.4% | $195.0M | 0.94% |
| 2021 Q4 | 2022-02-11 | Reduce | 1,688,780 | -67,118 | -3.8% | $237.7M | 1.14% |
| 2021 Q3 | 2021-11-12 | Add | 1,755,898 | 24,686 | +1.4% | $207.4M | 1.03% |
| 2021 Q2 | 2021-08-12 | Add | 1,731,212 | 6,799 | +0.4% | $200.7M | 1.00% |
| 2021 Q1 | 2021-05-13 | Reduce | 1,724,413 | -53,582 | -3.0% | $206.7M | 1.13% |
| 2020 Q4 | 2021-02-12 | Reduce | 1,777,995 | -132,242 | -6.9% | $194.7M | 1.20% |
| 2020 Q3 | 2020-11-13 | Add | 1,910,237 | 710,770 | +59.3% | $207.9M | 1.48% |
| 2020 Q2 | 2020-08-13 | Reduce | 1,199,467 | -252,951 | -17.4% | $109.7M | 0.81% |
| 2020 Q1 | 2020-05-14 | Reduce | 1,452,418 | -353,745 | -19.6% | $114.6M | 0.96% |
| 2019 Q4 | 2020-02-13 | Add | 1,806,163 | 5,195 | +0.3% | $156.9M | 1.05% |
| 2019 Q3 | 2019-11-13 | Add | 1,800,968 | 52,749 | +3.0% | $150.7M | 1.04% |
| 2019 Q2 | 2019-08-13 | Reduce | 1,748,219 | -89,609 | -4.9% | $147.0M | 1.03% |
| 2019 Q1 | 2019-05-14 | Reduce | 1,837,828 | -181,881 | -9.0% | $146.9M | 1.06% |
| 2018 Q4 | 2019-02-13 | Reduce | 2,019,709 | -255,139 | -11.2% | $146.1M | 1.17% |
| 2018 Q3 | 2018-11-14 | Reduce | 2,274,848 | -283,391 | -11.1% | $166.9M | 1.13% |
| 2018 Q2 | 2018-08-14 | Reduce | 2,558,239 | -826,002 | -24.4% | $156.0M | 1.11% |
| 2018 Q1 | 2018-05-15 | Reduce | 3,384,241 | -1,436,126 | -29.8% | $202.8M | 1.24% |
| 2017 Q4 | 2018-02-14 | Reduce | 4,820,367 | -33,200 | -0.7% | $275.1M | 1.62% |
| 2017 Q3 | 2017-11-14 | Reduce | 4,853,567 | -398,392 | -7.6% | $259.0M | 1.51% |
| 2017 Q2 | 2017-08-14 | Add | 5,251,959 | 243,161 | +4.9% | $255.3M | 1.41% |
| 2017 Q1 | 2017-05-15 | Add | 5,008,798 | 523,854 | +11.7% | $222.4M | 1.25% |
| 2016 Q4 | 2017-02-13 | Reduce | 4,484,944 | -25,404 | -0.6% | $172.3M | 0.93% |
| 2016 Q3 | 2016-11-10 | New | 4,510,348 | 4,510,348 | — | $190.7M | 0.90% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.